Strategikon releases Clinical Maestro LEAD for trial budget management

11th June 2020 (Last Updated June 11th, 2020 17:17)

Strategikon Pharma has released Cloud-based platform Clinical Maestro LEAD for ongoing trial budget management.

Strategikon releases Clinical Maestro LEAD for trial budget management
Clinical Maestro LEAD drives transparency and continuity into the trial accrual reporting. Credit: Michal Jarmoluk from Pixabay.

Strategikon Pharma has released Cloud-based platform Clinical Maestro LEAD for ongoing trial budget management.

Clinical Maestro LEAD drives transparency and continuity into the trial accrual reporting, as well as forecasting process.

It helps sponsors attain ‘budget certainty’ and make informed decisions. It will also identify risks sooner to maximise what is seen.

Strategikon Pharma founder and CEO Anca Copaescu said: “Input from our life sciences customers is that only tracking project milestones doesn’t offer enough insight into the actual completed tasks and study progress.

“They need to know what has been spent against what was planned without turning their entire team upside down. Clinical Maestro LEAD offers a new, modern approach to budget spend analysis and accrual reporting by introducing system-driven due diligence, and multi-dimensional spend and operational driver comparisons.

“This provides greater visibility into the timing and rate of expense. Having access to earned value analysis (EVA) in real-time keeps study teams ahead of the change curve and decreases incidence of unnecessary change orders.”

Clinical Maestro is an end-to-end Cloud-based platform to more efficiently budget, source, and manage complex clinical programmes. It added LEAD module to modernise the process of accrual and reforecasting for clinical trials.

Strategikon Pharma CCO Farah Ahmad said: “With the complexity level of today’s clinical trials, the use of manual, static tools like Excel to manage budgets is unsustainable. Especially with the impact of Covid-19, understanding forecast changes is critical.

“Clinical Maestro LEAD automates the entire EVA process with structured actual spend reporting and metrics so sponsors can bring order to their accrual and forecast process. Ultimately, sponsors get greater transparency that helps to deepen their Provider Partnerships.”

LEAD is part of the Clinical Maestro Sponsor Edition, which is a set of unified clinical business operations applications for managing clinical trials on a single Cloud-based platform.